Divi’s Laboratories Ltd. (DIVISLAB): Divi’s Laboratories Share Price hits fresh 52-week high on 26 August 2026
- August 26, 2026
- Posted by: Harsh Piplani
- Category: News
Divi’s Laboratories Share Price rose to Rs 8,890, up 2.42% today, and touched a fresh 52-week high with market capitalisation of Rs 2,25,648.29 crore.
Divi’s Laboratories Share Price moved to Rs 8,890 on 26 August 2026, up Rs 210 or 2.42% from the previous close of Rs 8,680. The stock touched a fresh 52-week high at Rs 8,893 and ended the session just below that level, while the company’s market capitalisation stood at Rs 2,25,648.29 crore. This makes Divi’s Laboratories Share Price and Divi’s Laboratories Share Price Today a key market update for readers tracking DIVISLAB on NSE and BSE. The supplied data confirms the price event, but it does not establish a company-specific catalyst. Even so, Divi’s Laboratories Stock News remains relevant because the share price is at its yearly high and the valuation, sector context and peer data provide useful background for stock analysis on Univest.
Divi’s Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 8,890 |
| Previous Close | Rs 8,680 |
| Today's Move | +Rs 210 (+2.42%) |
| Open | Rs 8,766.75 |
| High | Rs 8,893 |
| Low | Rs 8,700 |
| Turnover | Rs 3.71 crore |
| Market Capitalisation | Rs 2,25,648.29 crore |
Divi's Laboratories Ltd. (DIVISLAB) traded at Rs 8,890 versus the previous close of Rs 8,680, a rise of 2.42%. The stock opened at Rs 8,766.75, reached a high of Rs 8,893 and touched a low of Rs 8,700.
Divi’s Laboratories Share Price opened at Rs 8,766.75, moved between Rs 8,700 and Rs 8,893, and closed at Rs 8,890. The day’s rise of Rs 210 followed a previous close of Rs 8,680, while the fresh 52-week high of Rs 8,893 set the intraday ceiling for the session. Turnover stood at Rs 3.71 crore. In simple terms, today’s action shows the stock trading near the top of its daily range and finishing very close to its yearly high, which is why Divi’s Laboratories Share Price Today is drawing attention in the Indian stock market. For readers tracking Divi’s Laboratories Share Price Live, the verified numbers point to a strong session in price terms without adding any unsupported explanation for the move. Univest continues to track such share price updates for event-led stock news coverage.
Divi's Laboratories Ltd. (DIVISLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,25,648.29 crore |
| P/E Ratio | 78.78x |
| P/B Ratio | 13.05x |
| ROE | 16.19% |
| ROCE | 21.51% |
| EPS | Rs 110.18 |
| Book Value Per Share | Rs 665.36 |
| Dividend Yield | 0.35% |
Divi's Laboratories Ltd. (DIVISLAB) fundamental metrics show P/E 78.78x, P/B 13.05x, ROE 16.19%, ROCE 21.51%. These figures provide context only and are not a buy or sell signal.
Divi’s Laboratories Ltd. has a market capitalisation of Rs 225648.29 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 78.78x, P/B at 13.05x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.19% and ROCE of 21.51%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 110.18, book value per share of Rs 665.36, dividend yield of 0.35%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.32x, median ROE of 11.81%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 78.78x |
| Benchmark Median P/E | 30.32x |
| Benchmark Average P/E | 46.6x |
| Benchmark P/E Range | 2.94x to 717.81x |
| Company P/B Ratio | 13.05x |
| Benchmark Median P/B | 2.7x |
| Company ROE | 16.19% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 21.51% |
| Benchmark Median ROCE | 13.75% |
| Company Market Capitalisation | Rs 2,25,648.29 crore |
| Benchmark Median Market Cap | Rs 599.92 crore |
Divi's Laboratories Ltd. (DIVISLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 78.78x, which is above the benchmark median of 30.32x, a difference of +159.83%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Divi's Laboratories Ltd. (DIVISLAB) has a ROE of 16.19%, which is above the benchmark median of 11.81%, a difference of +37.09%. Divi's Laboratories Ltd. (DIVISLAB) has a ROCE of 21.51%, which is above the benchmark median of 13.75%, a difference of +56.44%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,891.11 | 85.81 | 20.85 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,15,926.93 | 34.03 | 3.26 | 11.83 | 16 |
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,58,248.99 | 38.03 | 5.32 | 14.85 | 19.11 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,09,825.17 | 24.98 | 4.18 | 19.69 | 21.39 |
| Lupin Ltd. | LUPIN | 1,00,134.44 | 17.99 | 4.18 | 27.11 | 28.86 |
Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 78.78x compared with the displayed peer median of 34.03x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.19% compares with a peer median of 19.69% across the companies shown in the table. ROCE stood at 21.51% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Divi's Laboratories Ltd. (DIVISLAB) has a market capitalisation of Rs 2,25,648.29 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Divi’s Laboratories
- Divi’s Laboratories Share Price touched Rs 8,893 during the session and closed at Rs 8,890.
- The stock rose Rs 210, or 2.42%, from the previous close of Rs 8,680.
- Divi’s Laboratories Share Price is at a fresh 52-week high and one-year high.
- The company’s market capitalisation is Rs 2,25,648.29 crore.
- Divi’s Laboratories has a P/E of 78.78, P/B of 13.05, ROE of 16.19% and ROCE of 21.51%.
About Divi’s Laboratories
Divi’s Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies the company within the Indian stock market universe tracked on NSE and BSE under DIVISLAB. Its reported financial indicators include revenue, net profit, EPS, book value and dividend yield, which provide a factual company profile for readers following Divi’s Laboratories Share Price, Divi’s Laboratories Company News and Divi’s Laboratories Latest News on Univest.
Track Divi’s Laboratories Share Price on Univest
Use Divi's Laboratories Ltd. (DIVISLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Divi’s Laboratories Share Price on Univest for live price updates, share price news, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also presents Divi’s Laboratories Share Price Today alongside company financials and sector context, helping users follow stock updates in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Divi's Laboratories Share Price today?
Ans. Divi's Laboratories Share Price is Rs 8,890. It was up Rs 210, or 2.42%, from the previous close of Rs 8,680 and finished near the day’s high of Rs 8,893.
Did Divi's Laboratories hit a fresh 52-week high?
Ans. Yes. Divi's Laboratories Share Price touched a fresh 52-week high of Rs 8,893 in today’s session and ended just below that level at Rs 8,890, according to the supplied price data.
What was Divi's Laboratories Share Price previous close?
Ans. The previous close for Divi's Laboratories Share Price was Rs 8,680. The stock opened higher at Rs 8,766.75 and traded between Rs 8,700 and Rs 8,893 during the session. The stock moved 2.42% during the session.
What is the market capitalisation of Divi's Laboratories?
Ans. Divi's Laboratories has a market capitalisation of Rs 2,25,648.29 crore. That places the company well above the healthcare sector median in the supplied benchmark set. The company operates in the Healthcare sector.
What does the valuation show for Divi's Laboratories Share Price?
Ans. Divi's Laboratories trades at a P/E of 78.78 and a P/B of 13.05. Both are above the sector benchmark medians of 30.32 and 2.70 in the supplied same-industry comparison. The stock moved 2.42% during the session.
How do ROE and ROCE look for Divi's Laboratories?
Ans. Divi's Laboratories reports ROE of 16.19% and ROCE of 21.51%. Both are above the sector benchmark medians, which provides useful context for Divi's Laboratories Share Price analysis. ROE stands at 16.19%.
How does Divi's Laboratories compare with its peers?
Ans. Divi's Laboratories has a higher market cap than several supplied peers, while its P/E sits above many and below some. Its ROE and ROCE also compare favourably with several listed peers.
Where can investors follow Divi's Laboratories Share Price updates?
Ans. Investors can follow Divi's Laboratories Share Price on Univest for live updates, stock news, company financials, sector context and key market metrics. The platform also tracks 52-week levels and valuation data.
